Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Colorectal Neoplasms, Hereditary Nonpolyposis

• Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
• A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
• Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer
• PD-1 Antibody Following Preoperative Chemoradiotherapy for Locally Advanced pMMR/MSS Rectal Cancer
• PD-1 Antibody for The Prevention of Adenomatous Polyps and Second Primary Tumors in Lynch Syndrome Patients
• Atorvastatin ± Aspirin in Lynch Syndrome Syndrome
• Omega 3 Fatty Acids in Colorectal Cancer (CRC) Prevention in Patients With Lynch Syndrome (COLYNE)
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
• Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
• Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
• Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome
• Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers
• Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome
• The Cancer of the Pancreas Screening-5 CAPS5)Study
• Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
• Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
• Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers